KYORIN Pharmaceutical
4569.T
A$15.67
Share price
0.34%
Change (1 day)
0.75%
Change (1 year)
Categories
KYORIN Pharmaceutical (4569.T) - Total debt
Total debt on the balance sheet as of March 2025 : A$0.28 Billion
According to KYORIN Pharmaceutical's latest financial reports the company's total debt is A$0.28 Billion. A company’s total debt is the sum of all current and non-current debts.
KYORIN Pharmaceutical - Total debt on balance sheet (from 2008 to 2025)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2024-03-31 | A$0.21 B | -11.11% |
| 2023-03-31 | A$0.23 B | 0.5% |
| 2022-03-31 | A$0.23 B | -8.89% |
| 2021-03-31 | A$0.26 B | -27.24% |
| 2020-03-31 | A$0.35 B | 17.54% |
| 2019-03-31 | A$0.30 B | 361.97% |
| 2018-03-31 | A$65.85 M | 1.37% |
| 2017-03-31 | A$64.96 M | -13.01% |
| 2016-03-31 | A$74.68 M | 72.39% |
| 2015-03-31 | A$43.32 M | 82.82% |
| 2014-03-31 | A$23.69 M | 14.09% |
| 2013-03-31 | A$20.77 M | -49.8% |
| 2012-03-31 | A$41.37 M | -52.47% |
| 2011-03-31 | A$87.04 M | 115.12% |
| 2010-03-31 | A$40.46 M | -47.76% |
| 2009-03-31 | A$77.46 M | 174.46% |
| 2008-03-31 | A$28.22 M | 80.22% |
| 2007-03-31 | A$15.66 M | -31.5% |
| 2006-03-31 | A$22.86 M | |
| 2005-03-31 | N/A |